Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Bacopa Monnieri | Ginkgo Biloba | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 300-450 mg/day of standardized extract (24-55% bacosides, typically Bacognize or Synapsa brands) | 120-240 mg/day of standardized extract (24% flavone glycosides, 6% terpene lactones) divided into 2-3 doses |
| Timing | With a fat-containing meal to improve absorption of fat-soluble bacosides. Morning or evening — some users report mild sedation. Minimum 8-12 weeks for full cognitive effects. | With or without food. Split into 2-3 doses throughout the day. Effects may take 4-6 weeks to manifest. |
| Cycle Duration | Ongoing; benefits accumulate over months. No strict cycling required. | Ongoing; no cycling required. Clinical trials typically run 22-26 weeks. |
| Evidence Level | strong_human | strong_human |
Active triterpenoid saponins (bacosides A and B) provide multifaceted neuroprotection: inhibition of acetylcholinesterase (AChE) and activation of choline acetyltransferase (ChAT) to enhance cholinergic neurotransmission; upregulation of tryptophan hydroxylase and serotonin transporter expression to modulate serotonergic tone; antioxidant neuroprotection via induction of superoxide dismutase and glutathione peroxidase; and reduction of beta-amyloid aggregation. Additionally enhances GABA signaling through GABA-A receptor subunit upregulation and glutamate decarboxylase activation.
300-450 mg/day of standardized extract (24-55% bacosides, typically Bacognize or Synapsa brands)
With a fat-containing meal to improve absorption of fat-soluble bacosides. Morning or evening — some users report mild sedation. Minimum 8-12 weeks for full cognitive effects.
Ongoing; benefits accumulate over months. No strict cycling required.
Standardized extract (EGb 761) contains flavonoid glycosides (24%) and terpene lactones (6% — ginkgolides A/B/C and bilobalide) that act through multiple pathways: potent free radical scavenging and inhibition of membrane lipid peroxidation; antagonism of platelet-activating factor (PAF) via ginkgolides; enhancement of cerebral blood flow through nitric oxide-mediated vasodilation and reduced blood viscosity; and increased prefrontal dopamine and acetylcholine release via acylated flavonol glycosides. Bilobalide provides direct neuroprotection against excitotoxicity and mitochondrial dysfunction.
120-240 mg/day of standardized extract (24% flavone glycosides, 6% terpene lactones) divided into 2-3 doses
With or without food. Split into 2-3 doses throughout the day. Effects may take 4-6 weeks to manifest.
Ongoing; no cycling required. Clinical trials typically run 22-26 weeks.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →